Find the latest pharmaceutical market place for formulations enquiry about Eribulin on PharmaCompass.com.

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various FDFs needed in Turkey [ENA23953]

A company that focuses on manufacturing and distribution of various finished formulations is looking for suppliers of Various FDFs for commercial purposes.
1. Eribulin Mesylate (0.88 mg/ 2 ml) Injections. The required quantity is 5,000 units.
2. Raltegravir (400 mg) Tablets. The required quantity is 1,200,000 units.

Reply

05 Sep 2025

Various FDFs needed in Thailand [ENA20665]

A company that focuses on the marketing and distribution of tablet and injectable dosage forms is looking for suppliers of various finished formulations for commercial purposes. The supplier must support this enquiry with dossiers, GMP & CoA.
1. Goserelin Acetate (3.6 mg & 10.8 mg) Injections
2. Everolimus (0.25 mg, 0.5 mg & 0.75 mg) Tablets
3. Fulvestrant (250 mg/ 5 ml) Injections
4. Mirabegron (50 mg) Tablets
5. Eribulin (1 mg & 0.88 mg/ 2 ml) Injections

Reply

26 Sep 2024

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA13030]

A company that deals in urology, women's health, oncology and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S, GMP and CoA.
1. Eribulin Mesylate (0.5 mg/ ml) Vials. The required quantity is 6,000 units.
2. Vandetanib (100 mg) Tablets. The required quantity is 1,500 units.
3. Dantrolene Sodium (20 mg) Tablets. The required quantity is 810 units.
4. Naltrexone Hydrochloride (1000 mg) Implants. The required quantity is 2,500 units.

Reply

17 Mar 2022

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA11135]

A company that deals in oncology, urology, women's health and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S GMP and CoA.
1. Clobazam (10 mg) Tablets
2. Cysteamine Bitartrate (50 mg & 150 mg) Tablets
3. Defibrotide (200 mg) Vials
4. Diazoxide (25 mg & 100 mg) Tablets
5. Dronedarone (400 mg) Tablets
6. Eribulin Mesylate (0.44 mg/ ml) Vials

Reply

17 Aug 2021